According to the Zhitong Finance App, Hengrui Pharmaceutical (01276) announced that on October 13, 2026, the company spent RMB 1999.95 million to repurchase 442,600 A-shares, with a repurchase price of RMB 44.8-45.55 per share.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.